Renin-angiotensin-aldosterone system blockers and cardiovascular outcomes: a meta-analysis of randomized clinical trials
Date
2017Author
Ozdemir, Oktay
Uresin, Yagiz
Kizilirmak, Pinar
Ongen, Zeki
Tokgozoglu, Lale
Avci, Burcak Kilickiran
Metadata
Show full item recordAbstract
Objective: Hypertension is the most prevalent modifiable risk factor for cardiovascular (CV) and cerebrovascular morbidity and mortality. This study aimed to assess the effects of renin-angiotensin-aldosterone system (RAAS) blockade on CV outcomes.
Collections
- Makale [92797]